About Natalizumab
Class: | Monoclonal antibody (integrin inhibitor)
Use: | Treatment of relapsing forms of multiple sclerosis (MS) and Crohn's disease
Adult dose: | 300 mg administered as an intravenous infusion every 4 weeks
Pediatric dose: | Not established; safety and efficacy in pediatric patients have not been determined
Side effects: | Headache, fatigue, nausea, infusion-related reactions, increased risk of infections
Contraindications: | History of progressive multifocal leukoencephalopathy (PML)
Drug Class
Monoclonal antibody (integrin inhibitor)
Uses & Indications
Treatment of relapsing forms of multiple sclerosis (MS) and Crohn's disease
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: Biogen Idec B.V., NETHERLANDS
Package Size
15ml Vial
Price & Supplier
Price in UAE: AED 14231.10
Dosage Information
Adult Dose
300 mg administered as an intravenous infusion every 4 weeks
Pediatric Dose
Not established; safety and efficacy in pediatric patients have not been determined
Side Effects
Headache, fatigue, nausea, infusion-related reactions, increased risk of infections
Contraindications & Precautions
History of progressive multifocal leukoencephalopathy (PML), active infections, hypersensitivity to Natalizumab or any component of the formulation
Important Warnings
Risk of PML, serious infections, liver injury; monitor for signs and symptoms of PML and infections; patients should be enrolled in the TOUCH prescribing program for risk management
Related Medicines in Same Category
See also: Other Monoclonal antibody (integrin inhibitor) medicines available in UAE pharmacies
Vedolizumab
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.